Prospective Study To Assess The Outcomes Of Nitrous Oxide Cryoablation For Treatment Of Duodenal Adenomas In Patients With Hereditary Conditions Such As FAP, HNPCC
To learn how well nitrous oxide cryoballoon ablation, a procedure that uses extreme cold to destroy abnormal tissue, works in treating flat duodenal adenomas (abnormal growths in the small intestine) in people with FAP or Lynch syndrome (HNPCC).
研究概览
地位
详细说明
Primary Objectives Evaluate the Efficacy of Nitrous Oxide Cryoballoon Ablation: To determine the clinical efficacy of nitrous oxide cryoballoon ablation in achieving complete eradication of duodenal adenomas in patients with Familial Adenomatous Polyposis (FAP) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC). The primary endpoint will be the complete eradication of adenomas at 12 months post-procedure, confirmed by endoscopy and histology.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Marta Davila, MD
- 电话号码:713-563-4382
- 邮箱:MDavila@mdanderson.org
学习地点
-
-
Texas
-
Houston、Texas、美国、77030
- UT MD Anderson Cancer Center
-
接触:
- Marta Davila, MD
- 电话号码:713-563-4382
- 邮箱:MDavila@mdanderson.org
-
首席研究员:
- Marta Davila, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Eligibility Criteria
- Participants aged 20-75 years.
- Confirmed diagnosis of FAP or HNPCC.
- Presence of flat duodenal adenomas confirmed by histology.
- Ability to understand and willingness to sign an informed consent form.
Exclusion Criteria
- Presence of invasive duodenal cancer.
- Severe comorbidities that would contraindicate endoscopic procedures.
- Allergy or intolerance to components of the nitrous oxide cryoballoon system.
- Previous duodenal surgery affecting the study area.
- Active gastrointestinal bleeding. Pregnancy
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:EGD + CBA
Endoscopy with Cryoballoon Ablation Treatment of Duodenal Adenomas |
Esophagogastroduodenoscopy with cryoballoon ablation will be performed every 3 months to a maximum of 5 procedures. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Safety and adverse events (AEs)
大体时间:Through study completion; an average of 1 year.
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
Through study completion; an average of 1 year.
|
合作者和调查者
调查人员
- 首席研究员:Marta Davila, MD、UT MD Anderson Cancer Center
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.